Core Laboratories NV Aktie
20,80
EUR
-2,00
EUR
-8,77
%
Core Laboratories NV Aktie Analyse
| 29.10.18 | Core Laboratories NV Market Perform | Cowen and Company, LLC | |
| 10.10.18 | Core Laboratories NV Underperform | Wolfe Research | |
| 07.09.17 | Core Laboratories NV Outperform | RBC Capital Markets | |
| 21.04.17 | Core Laboratories NV Buy | Loop Capital | |
| 13.12.16 | Core Laboratories NV Neutral | UBS AG | |
| 22.04.16 | Core Laboratories NV Outperform | RBC Capital Markets | |
| 22.04.16 | Core Laboratories NV Market Perform | Cowen and Company, LLC | |
| 28.01.16 | Core Laboratories NV Outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 12.01.16 | Core Laboratories NV Perform | Oppenheimer & Co. Inc. | |
| 26.10.15 | Core Laboratories NV Market Perform | Cowen and Company, LLC | |
| 18.09.15 | Core Laboratories NV Outperform | RBC Capital Markets | |
| 30.01.15 | Core Laboratories NV Sector Perform | Scotia Howard Weil | |
| 24.10.14 | Core Laboratories NV Sector Perform | Howard Weil | |
| 02.11.12 | Core Laboratories NV buy | ING | |
| 19.09.12 | Core Laboratories NV outperform | William Blair | |
| 19.12.06 | Core Laboratories NV Neutral | JP Morgan | |